OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
Wanzun Lin, Li Chen, Haojiong Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Current Strategies for Exosome Cargo Loading and Targeting Delivery
Haifeng Zeng, Shaoshen Guo, Xuancheng Ren, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1416-1416
Open Access | Times Cited: 143

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 79

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Xiangyu Wu, Tianhang Li, Rui Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 61

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26

Advanced Delivery Systems for Gene Editing: A Comprehensive Review from the GenE-HumDi COST Action Working group
Alessia Cavazza, Francisco J Molina-Estevez, Álvaro Plaza Reyes, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102457-102457
Open Access | Times Cited: 2

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 34

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 13

Exosomal noncoding RNA: A potential therapy for retinal vascular diseases
Jong-Ik Heo, Juhee Ryu
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102128-102128
Open Access | Times Cited: 10

Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8

USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation
Na Shao, Lei Xi, Yangfan Lv, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7

CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 7

The interplay of Cxcl10+/Mmp14+ monocytes and Ccl3+ neutrophils proactively mediates silica-induced pulmonary fibrosis
Demin Cheng, Wenxiu Lian, Ting Wang, et al.
Journal of Hazardous Materials (2024) Vol. 467, pp. 133713-133713
Closed Access | Times Cited: 6

Application of exosomes in tumor immunity: recent progresses
Haiyan Qiu, Junting Liang, Guang Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5

Tigulixostat Alleviates Hyperuricemic Nephropathy by Promoting M2 Macrophage Polarization
Lina Xue, Qianru Tao, Haining Chang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 17-30
Open Access

RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access

Differential protein and mRNA cargo loading into engineered large and small extracellular vesicles reveals differences in in vitro and in vivo assays
Zuriñe Erana-Perez, Manoli Igartúa, Edorta Santos‐Vizcaíno, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 951-966
Closed Access

The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access

YTHDF1-targeting nanoassembly reverses tumoral immune evasion through epigenetics and cell cycle modulation
Hongting Liu, X Zhang, Feng Ding, et al.
Journal of Controlled Release (2025)
Closed Access

RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond
Yuan Ding, Cuicui Liu, Ke‐Da Yu
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access

Bioorthogonal In Situ Polymerization of Dendritic Agents for Hijacking Lysosomes and Enhancing Antigen Presentation in Cancer Cells
Dan Zhong, Xingyu Hou, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 4

Extracellular vesicles in cancer therapy: Roles, potential application, and challenges
Ting Liu, Li Sun, Yong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189101-189101
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top